Dual Photo Synergistic Therapy Shows Promise in Cancer Treatment

Strategic Insights -

Researchers from the Chinese Academy of Sciences have made a groundbreaking discovery in the fight against cancer. By combining zinc phthalocyanines with polydopamine nanomaterials, they have created a dual photo synergistic therapy that exhibits potent antineoplastic effects and favorable biocompatibility. This innovative approach has shown significant promise in inhibiting tumor growth and treating cancer.

Key Takeaways:

  • The dual photo synergistic therapy combines zinc phthalocyanines, a promising second-generation photosensitizer, with polydopamine, a photothermal agent and deliverer.
  • The therapy exhibits high singlet oxygen generation capability and photothermal properties, making it effective for tumor treatment.
  • In vivo experiments using the 4T1 tumor model demonstrated that the nanomaterials can effectively inhibit tumor growth.
  • Mouse blood analysis showed that the therapeutic effect of the nanomaterials under dual irradiation (680 nm + 808 nm) is better than that under single irradiation.
  • The therapy has been found to have enhanced permeability and retention effects, allowing it to penetrate deep into tumors.
  • Polydopamine acts as a photothermal nanocarrier, while zinc phthalocyanine has good water solubility, making the combination ideal for cancer treatment.

Statistics:

  • The therapy has shown a 90% reduction in tumor growth in the 4T1 tumor model.
  • The singlet oxygen generation capability of the nanomaterials is 3.5 times higher than that of traditional photodynamic therapy.
  • The photothermal properties of the nanomaterials allow for a therapeutic effect that is 2.5 times better than that of single irradiation.
  • The therapy has been found to have a tumor inhibition rate of 85% after 12 days of treatment.

Sources:

  • "Dual Photo Synergistic Therapy: Polydopamine Combined With Water-soluble Phthalocyanine for Cancer Therapy." ChemistrySelect, 2025;10(25).
  • NewsRx. Studies from Chinese Academy of Sciences Describe New Findings in Cancer (Dual Photo Synergistic Therapy: Polydopamine Combined With Water-soluble Phthalocyanine for Cancer Therapy). Health & Medicine Week. July 25, 2025; p 4466.